Plasma concentrations of inflammatory biomarkers, including but not limited to tumor necrosis factor (TNF)-a, interleukin (IL)-6, and C-reactive protein (CRP), are increased twofold in T2D [2]. This evidence concerns the gene CRP and type 2 diabetes mellitus.